Michel de Wilde
Direktor/Vorstandsmitglied bei VBI VACCINES INC.
Vermögen: 999 $ am 30.04.2024
Aktive Positionen von Michel de Wilde
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VBI VACCINES INC. | Direktor/Vorstandsmitglied | 01.05.2016 | - |
Independent Dir/Board Member | 01.05.2016 | - | |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Direktor/Vorstandsmitglied | 01.07.2014 | - |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Direktor/Vorstandsmitglied | 01.07.2014 | - |
Karriereverlauf von Michel de Wilde
Ehemalige bekannte Positionen von Michel de Wilde
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 01.12.2014 | 01.12.2019 |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.06.2013 |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.06.2013 |
VBI VACCINES INC | Direktor/Vorstandsmitglied | 25.07.2014 | - |
Independent Dir/Board Member | 25.07.2014 | - |
Ausbildung von Michel de Wilde
Université Libre de Bruxelles | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Belgien | 2 |
Frankreich | 2 |
Operativ
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VBI VACCINES INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
VBI Vaccines, Inc. /Old/
VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
Verband Beratender Ingenieure VBI
Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Commercial Services |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
- Börse
- Insiders
- Michel de Wilde
- Erfahrung